In pneumococcal meningitis, adjuvant therapy with an ONOO− scavenger reduces the number of CSF leukocytes concentrations and reduces the brain concentrations of IL-1β and MIP-2 [46]. This evidence concerns the gene IL1B and pneumococcal meningitis.